Status:

RECRUITING

Implementation of DWM in Dutch SMEs

Lead Sponsor:

VU University of Amsterdam

Collaborating Sponsors:

World Health Organization

University of Copenhagen

Conditions:

Anxiety

Depression

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this cluster randomized controlled trial is to explore if mental health in Dutch small and medium-sized enterprises (SMEs) can be improved by the World Health Organization's online program...

Detailed Description

Rationale: Small and medium-sized enterprises (SMEs) often lack the resources to combat the negative consequences of work stressors (e.g., high workplace digitalization). This puts their employees at ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (SMEs):
  • Having 10 to 250 employees
  • Being located in the Netherlands
  • (In case of insufficient recruitment among SMEs, a mitigation strategy is to recruit individual departments from larger organizations)
  • Inclusion Criteria (Individual participants):
  • 18 years or older
  • Having elevated levels of psychological distress (Kessler Psychological Distress Scale; K10 scores \> 15.9)
  • Sufficient literacy and mastery (written and spoken) of one of the languages the DWM intervention is being delivered in (i.e., Dutch or English)
  • Having access to an electronic device with internet access to follow the intervention
  • Written informed consent before entering the study
  • Exclusion Criteria (Individual participants):
  • Imminent suicide risk, or expressed acute needs or protection risks that require immediate follow-up
  • Currently receiving specialized psychological treatment (e.g., EMDR or CBT) at the time of screening
  • In case of current psychotropic medication use: being on an unstable dose for at least 2 months or a change in dosage over the past 2 months.
  • Having participated in the preceding ASCEND trial as supervisor (see NCT ID: NCT06989398)

Exclusion

    Key Trial Info

    Start Date :

    May 19 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2026

    Estimated Enrollment :

    518 Patients enrolled

    Trial Details

    Trial ID

    NCT06979089

    Start Date

    May 19 2025

    End Date

    September 1 2026

    Last Update

    December 5 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Vrije Universiteit Amsterdam

    Amsterdam, North Holland, Netherlands, 1081 HV